Should Unclassifiable Ild Be Treated Like Ipf

Should Unclassifiable ILD be Treated like IPF? | Joao A. de Andrade, MD

Pulmonary Fibrosis Foundation

Idiopathic Interstitial Lung Diseases: When a Cause is Truly Unidentifiable Webinar

Pulmonary Fibrosis Foundation

Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype

American Thoracic Society

Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic Confidence

American Thoracic Society

Are all ILD cases IPF?

Interstitial Lung Disease Info

Idiopathic Pulmonary Fibrosis - 2018

UofL Dept. of Medicine Grand Rounds: Dr. Abishek Singla

Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical Care

American Thoracic Society

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

American Thoracic Society

Progressive Pulmonary Fibrosis: What Patients Need to Know webinar

Pulmonary Fibrosis Foundation

Toby Maher, ERS 2019 – Pirfenidone in Patients with Progressive Fibrosing Unclassifiable ILD

Touch Medical Media Services

PH-ILD: Does Treatment Improve Outcomes? | Steve Nathan, MD

Pulmonary Fibrosis Foundation

Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Community Pulmonologists and ILD Fellows | PFF Summit 2021

Pulmonary Fibrosis Foundation

Treatment Principles: IPF is Unpredictable - Interstitial Lung Disease: Altering the Disease Course

Annenberg Center for Health Sciences

Community Pulmonologists and ILD Fellows | PFF Summit

Pulmonary Fibrosis Foundation

Progressive Fibrotic ILD | Kevin Flaherty, MD, MS

Pulmonary Fibrosis Foundation

Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF)

National Jewish Health

Newly Diagnosed with an Interstitial Lung Disease

American Lung Association

Interstitial Lung Disease (ILD) | Did You Know these Facts About Interstitial Lung Disease

Advancells: Stem Cell Research & Development